NewLink Genetics (NLNK) Enters $40M Stock Controlled Equity Offering Sales Agreement
Tweet Send to a Friend
NewLink Genetics (NASDAQ: NLNK) disclosed the following in a U.S. SEC filing on Tuesday:Section 1 - Registrant’s Business and OperationsItem ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
